QuidelOrtho Statistics
Total Valuation
QuidelOrtho has a market cap or net worth of $3.02 billion. The enterprise value is $5.65 billion.
Important Dates
The next estimated earnings date is Tuesday, February 11, 2025, after market close.
| Earnings Date | Feb 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
QuidelOrtho has 67.26 million shares outstanding. The number of shares has increased by 0.26% in one year.
| Current Share Class | 67.26M |
| Shares Outstanding | 67.26M |
| Shares Change (YoY) | +0.26% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 1.41% |
| Owned by Institutions (%) | 91.17% |
| Float | 62.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 21.30 |
| PS Ratio | 1.07 |
| Forward PS | 1.08 |
| PB Ratio | 0.95 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 30.25 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.01 |
| EV / EBITDA | 9.63 |
| EV / EBIT | 44.28 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.87.
| Current Ratio | 1.38 |
| Quick Ratio | 0.67 |
| Debt / Equity | 0.87 |
| Debt / EBITDA | 4.30 |
| Debt / FCF | n/a |
| Interest Coverage | 0.66 |
Financial Efficiency
Return on equity (ROE) is -45.79% and return on invested capital (ROIC) is 1.17%.
| Return on Equity (ROE) | -45.79% |
| Return on Assets (ROA) | 1.04% |
| Return on Capital (ROIC) | 1.17% |
| Revenue Per Employee | $396,859 |
| Profits Per Employee | -$262,901 |
| Employee Count | 7,100 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 2.62 |
Taxes
| Income Tax | -133.20M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.53% in the last 52 weeks. The beta is 0.10, so QuidelOrtho's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -38.53% |
| 50-Day Moving Average | 40.11 |
| 200-Day Moving Average | 41.15 |
| Relative Strength Index (RSI) | 62.70 |
| Average Volume (20 Days) | 1,168,671 |
Short Selling Information
The latest short interest is 3.91 million, so 5.82% of the outstanding shares have been sold short.
| Short Interest | 3.91M |
| Short Previous Month | 3.83M |
| Short % of Shares Out | 5.82% |
| Short % of Float | 6.30% |
| Short Ratio (days to cover) | 3.54 |
Income Statement
In the last 12 months, QuidelOrtho had revenue of $2.82 billion and -$1.87 billion in losses. Loss per share was -$27.85.
| Revenue | 2.82B |
| Gross Profit | 1.34B |
| Operating Income | 127.60M |
| Pretax Income | -1.99B |
| Net Income | -1.87B |
| EBITDA | 586.50M |
| EBIT | 127.60M |
| Loss Per Share | -$27.85 |
Full Income StatementBalance Sheet
The company has $146.00 million in cash and $2.78 billion in debt, giving a net cash position of -$2.63 billion or -$39.16 per share.
| Cash & Cash Equivalents | 146.00M |
| Total Debt | 2.78B |
| Net Cash | -2.63B |
| Net Cash Per Share | -$39.16 |
| Equity (Book Value) | 3.19B |
| Book Value Per Share | 47.42 |
| Working Capital | 385.30M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $99.70 million and capital expenditures -$196.50 million, giving a free cash flow of -$96.80 million.
| Operating Cash Flow | 99.70M |
| Capital Expenditures | -196.50M |
| Free Cash Flow | -96.80M |
| FCF Per Share | -$1.44 |
Full Cash Flow StatementMargins
Gross margin is 47.57%, with operating and profit margins of 4.53% and -66.25%.
| Gross Margin | 47.57% |
| Operating Margin | 4.53% |
| Pretax Margin | -70.97% |
| Profit Margin | -66.25% |
| EBITDA Margin | 20.81% |
| EBIT Margin | 4.53% |
| FCF Margin | n/a |
Dividends & Yields
QuidelOrtho does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.26% |
| Shareholder Yield | -0.26% |
| Earnings Yield | -61.89% |
| FCF Yield | -3.21% |
Dividend DetailsAnalyst Forecast
The average price target for QuidelOrtho is $53.43, which is 19.16% higher than the current price. The consensus rating is "Buy".
| Price Target | $53.43 |
| Price Target Difference | 19.16% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
QuidelOrtho has an Altman Z-Score of 1.18 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.18 |
| Piotroski F-Score | 5 |